AstraZeneca Plc said a “careful” review of all available data of the more than 17 million people in the European Union and the U.K. it has vaccinated against so far against Covid-19 shows no evidence of an increased risk of pulmonary embolism, deep vein thrombosis (DVT) or thrombocytopenia.
The company says it is continually monitoring the safety of its vaccine.
DISCLAIMER: The Views, Comments, Opinions, Contributions and Statements made by Readers and Contributors on this platform do not necessarily represent the views or policy of Multimedia Group Limited.
Latest Stories
-
‘Tribalism, partisanship and lawlessness are the biggest obstacles to our development’ – Togbe Afede XIV
3 mins -
Police vow to arrest South African miners as standoff continues
35 mins -
Togbe Afede XIV livid about state of Ghana’s economy, scandals in government
45 mins -
Top Republican says Trump nominees are ‘disruptors’
55 mins -
Undocumented migrants hope Trump mass deportations only ‘for criminals’
1 hour -
Final phase for mass rape trial that has horrified France
1 hour -
Trump, Musk and new cabinet nominees celebrate at UFC
2 hours -
‘Anointed by God’: The Christians who see Trump as their saviour
2 hours -
‘My parents drove me to raves aged 15’, says Charli XCX
2 hours -
Venezuela frees more than 100 arrested after disputed election result
2 hours -
‘Record breaking’ 60m homes watched Tyson vs Paul fight, Netflix says
2 hours -
Musk rebuked after siding with Meloni on Italy’s foreign migrant centres
3 hours -
GPL 2024/25: Young Apostles hand Samartex first home defeat since March
4 hours -
Unconventional Trump brings openings and perils for Africa
5 hours -
Iseguri Initiative fights teenage pregnancy and early child marriage
5 hours